CNS Pharmaceuticals, Inc.

NASDAQ:CNSP

0.1131 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -18.851-15.274-14.037-9.458-3.877-7.392-0.219
Depreciation & Amortization 0.0040.0120.0130.0110.00200
Deferred Income Tax -1.3220-0.7150000
Stock Based Compensation 1.0071.2031.7241.2930.4770.110.12
Change In Working Capital 3.6993.164-1.2390.834-0.4260.0840.047
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables 1.3221.70.5760.6570.1540.0710.057
Other Working Capital 2.3771.464-1.8150.177-0.5790.012-0.01
Other Non Cash Items 1.3220.3370.7150.0020.276.4810.002
Operating Cash Flow -14.14-10.558-13.538-7.318-3.553-0.716-0.112
Investing Activities:
Investments In Property Plant And Equipment -0.004-0.004-0.006-0.018-0.0200
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow -0.004-0.004-0.006-0.018-0.0200
Financing Activities:
Debt Repayment -0.439-0.428-0.477-0.043-0.035-0.184-0.122
Common Stock Issued 5.07616.0384.65414.22210.2950.3910.101
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -0.2030.0030.333-0.0450.010.770.535
Financing Cash Flow 4.63715.6134.50914.13410.261.1610.223
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -9.5075.051-9.0356.7986.6860.4450.111
Cash At End Of Period 0.54910.0555.00514.0397.2410.5550.111